Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Apple Inc. (AAPL), Mylan NV (MYL) & More: Here’s Why These Stocks Register Significant Intraday Moves


Markets opened strong today and remained in the green as the Fed’s FOMC said that it is not going to increase the interest rates this month. 

Meanwhile, a number of stocks, including Apple Inc. (NASDAQ:AAPL), Mylan NV (NASDAQ:MYL), Novavax Inc. (NASDAQ:NVAX), AK Steel Holding Corporation (NYSE:AKS) and ENSCO PLC (NYSE:ESV), are in the spotlight today and are registering significant moves. Let’s take a closer look at the events that put these stocks on investors radars and see what the funds from our database think about them.

While there are many metrics that investors can assess in the investment process, hedge fund sentiment is something that is often overlooked. However, hedge funds and other institutional investors allocate significant resources while making their bets and their long-term focus makes them the perfect investors to emulate. This is supported by our research, which determined that following the small-cap stocks that hedge funds are collectively bullish on can help a smaller investor beat the S&P 500 by around 95 basis points per month (see more details here).

Ellica /

Ellica /

Apple Inc. (NASDAQ:AAPL)  is one of the most popular and most-followed stocks and it is in the spotlight today amid news that it might acquire the British Luxury car maker McLaren. This news follows the previous news of Apple stalling its in-house development of autonomous cars. A report by the Financial Times claims that Apple “is considering a full takeover of McLaren or a strategic investment.” Among the funds we track, 116 funds held $10.67 billion worth of Apple’s stock at the end of June, having amassed 2% of its outstanding stock, compared to 152 investors that held $14.82 million worth of shares a quarter earlier.

Follow Apple Inc. (NASDAQ:AAPL)
Trade (NASDAQ:AAPL) Now!

Mylan NV (NASDAQ:MYL) is showing a little downcast trend as its CEO Heather Bresch is on Capitol Hill today to testify before the House Oversight Committee. The company’s policy of drastically increasing the price of its EpiPen allergic reaction treatment – and its resulting controversy – has caused negative impact on its stock price. The number of funds from our database long Mylan declined to 44 from 51 during the second quarter, while the total value of their holdings declined to $1.96 billion from $2.05 billion.

Follow Mylan Inc. (NASDAQ:MYL)
Trade (NASDAQ:MYL) Now!

Novavax Inc. (NASDAQ:NVAX)’s stock has surged by more than 24% as it continues to recover from a drop registered last week on the back of disappointing study results (see articles). Among the funds we track, 16 funds held $70 million worth of Novavax Inc. (NASDAQ:NVAX)’s stock in aggregate at the end of June, having amassed 3.60% of its outstanding stock, compared to 18 investors that held $59 million worth of shares a quarter earlier.

Follow Novavax Inc (NASDAQ:NVAX)
Trade (NASDAQ:NVAX) Now!

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.